Clinical trial
A Study: Pure CBD as Single-agent for Solid Tumor.
NCT02255292 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study: Pure CBD as Single-agent for Solid Tumor.
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2014
- Completion date
- July 31, 2015
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
solid tumor